Vitamin D Supplementation and TB

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Tuberculosis, Vitamin D, Immunity

In brief

The goal of this study is to understand the effects of vitamin D supplementation on immunological outcomes among patients with tuberculosis.

Key facts

Study ID

NCT01992263

Run by

Cornell University

People needed

200

Starts

2021-06-01

Expected to finish

2023-02-01

Last updated by the study team

2020-09-09

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active TB diagnosis by GeneXpert
• HIV infection status (according to AMC HIV clinic medical records of enzyme-linked immunosorbent assay [ELISA] results)

You may not qualify if…

• Children (<18 years of age)
• 60 years of age
• Pregnant at baseline
• Other severe complications or illnesses requiring hospitalization
• Received TB treatment for greater than 4 weeks in the past 5 years
• Refused to participate
• Residing in a geographic location > 1 hour from AMC (by public transit)

Where it is running

• Cornell University — Ithaca, New York, United States
• Arogyavaram Medical Centre (AMC) — Madanapalle, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.